Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2
BackgroundAlthough tremendous success has been achieved in the development and deployment of effective COVID-19 vaccines, developing effective therapeutics for the treatment of those who do come down with the disease has been with limited success. To repurpose existing drugs for COVID-19, we previou...
Main Authors: | Shaibu Oricha Bello, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, Aishatu Yahaya Bello, Yusuf Yahaya Deeni, Ifeoma Okoye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1273982/full |
Similar Items
-
Innovative, rapid, high-throughput method for drug repurposing in a pandemic—A case study of SARS-CoV-2 and COVID-19
by: Shaibu Oricha Bello, et al.
Published: (2023-03-01) -
Attitude of nurses and pharmacists on adverse drug reactions reporting in selected hospitals in Sokoto, Northwest Nigeria
by: Muhammad Tukur Umar, et al.
Published: (2016-01-01) -
Random effects meta-analysis of COVID-19/S. aureus partnership in co-infection
by: Adeiza, Suleiman Shuaibu, et al.
Published: (2020-11-01) -
NRF2 inhibition causes repression of ATM and ATR expression leading to aberrant DNA Damage Response
by: Hilal S Khalil, et al.
Published: (2015-03-01) -
Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
by: Abdullahi Bello Umar, et al.
Published: (2020-10-01)